ELV logo

Elevance Health, Inc. Stock Price

NYSE:ELV Community·US$80.8b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 199 Fair Values set on narratives written by author

ELV Share Price Performance

US$363.51
-16.14 (-4.25%)
US$387.16
Fair Value
US$363.51
-16.14 (-4.25%)
6.1% undervalued intrinsic discount
US$387.16
Fair Value
Price US$363.51
AnalystConsensusTarget US$387.16
NateF US$390.54
AnalystHighTarget US$507.00

ELV Community Narratives

AnalystConsensusTarget·
Fair Value US$387.16 6.1% undervalued intrinsic discount

ELV: Margin Recovery Will Drive Upside Despite ACA Headwinds And Premium Increases

0users have liked this narrative
0users have commented on this narrative
106users have followed this narrative
NateF·
Fair Value US$390.54 6.9% undervalued intrinsic discount

ELV Market Outlook

1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystHighTarget·
Fair Value US$495.7 26.7% undervalued intrinsic discount

Aging Trends And Digital Integration Will Expand Managed Care Markets

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
ELV logo
Elevance Health

ELV Market Outlook

Elevance Health, Inc. (NYSE: ELV) is a prominent player in the health benefits industry, offering a range of services including medical, pharmaceutical, dental, and behavioral health plans.Read more

View narrative
147
users have viewed this narrative
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
US$390.54
6.9% undervalued intrinsic discount
NateF's Fair Value
Revenue
6.79% p.a.
Profit Margin
3.69%
Future PE
13.33x
Price in 2029
US$546.7
US$387.16
6.1% undervalued intrinsic discount
Revenue
3.46% p.a.
Profit Margin
3.43%
Future PE
13.24x
Price in 2028
US$472.38
US$495.7
26.7% undervalued intrinsic discount
Revenue
7.43% p.a.
Profit Margin
3.6%
Future PE
14.73x
Price in 2028
US$603.15

Trending Discussion

Updated Narratives

ELV logo

ELV Market Outlook

Fair Value: US$390.54 6.9% undervalued intrinsic discount
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ELV logo

ELV: ACA Subsidy Uncertainty Will Pressure Membership And Earnings Visibility

Fair Value: US$320 13.6% overvalued intrinsic discount
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ELV logo

ELV: Margin Recovery From Medicaid Pressures Will Unfold Amid Regulatory Shifts

Fair Value: US$387.16 6.1% undervalued intrinsic discount
106 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued established dividend payer.

0 Risks
4 Rewards

Elevance Health, Inc. Key Details

US$194.8b

Revenue

US$143.7b

Cost of Revenue

US$51.2b

Gross Profit

US$45.6b

Other Expenses

US$5.5b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Jan 28, 2026
24.90
26.26%
2.84%
72.8%
View Full Analysis

About ELV

Founded
2001
Employees
104200
CEO
Gail Boudreaux
WebsiteView website
www.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. It also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, the company provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. It provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Recent ELV News & Updates

Recent updates

No updates